IANS | 01 Oct, 2023
Advent International, one of the largest global private equity firms,
has chosen Hyderabad as the headquarters for its Cohance Lifesciences
and plans to invest $2 billion.
Telangana’s industry Minister K.T.
Rama Rao revealed this on Friday. He posted on ‘X’ that he was ecstatic
to share that the leading global private equity firm Advent
International has chosen Hyderabad as the headquarters for its 'Cohance
platform', with a cumulative whopping investment of USD 2 Billion
(approx Rs 16,650 crore).
Last year, Advent International had
announced the launch of Cohance Lifesciences, a new brand identity for
its API and CDMO platform.
The minister said he had the
opportunity to meet with Pankaj Patwari, Managing Director, and
Vaidheesh Annaswamy, Operating Partner, to discuss their investment and
the ambitious growth plans.
“I'm delighted that the company will
be establishing a greenfield R&D lab in Hyderabad, underlining the
city's significance in the pharmaceutical sector. Their aggressive
growth plans are a testament to Hyderabad's growing influence in the
Pharma & Life Sciences sector,” he said.
“I am confident that
Advent will continue to thrive in Telangana, and we will continue to
extend unwavering support to our industry partners in their growth
endeavours,” he added.
KTR also welcomed a third investment from Welspun World group in Telangana in the form of Sintex BAPL Limited.
Sintex
BAPL Ltd., a wholly owned subsidiary of Welspun Corp Ltd, is set to
establish a water tanks and PVC pipes manufacturing unit with an
investment of Rs 350 crore. The minister on Thursday laid the foundation
stone for the unit that will create 1,000 jobs.
The minister
thanked Welspun Group chairman Balkrishan Goenka for his commitment to
invest Rs 5,000 crore in Telangana creating employment to 50,000
(directly and indirectly) in Chandanvelli region of Rangareddy district.